UCLA's Dr. Stuart Holden Interviewed by The Life Sciences

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
UCLA's Dr. Stuart Holden Interviewed by The Life Sciences Report

SAN FRANCISCO, CA --(Marketwired - April 21, 2016) - Solid tumors are typically managed with surgical resection, chemotherapy, radiation and biologics, but it's the secondary tumor mass, the metastasis, that kills patients. Dr. Stuart Holden of the UCLA Institute of Urologic Oncology understands the importance of targeting metastatic disease, which is driven by different genetic factors than the primary tumor from which it arose -- a fact that oncologists are just now coming to grips with. In this interview with The Life Sciences Report , Dr. Holden describes an essential target in aggressive prostate cancers, and a drug with the potential to address that target and extend the lives of thousands of men.

Included in this interview is: Arno Therapeutics Inc.  ( OTCQB : ARNI ).

The Life Sciences Report : You've worked on the front lines of prostate cancer for more than 36 years. What is the most dramatic change you've seen?

Stuart Holden : I don't know if it's the most dramatic, but I would say the most game-changing was the development of the prostate specific antigen (PSA) assay. It was developed academically around 1977, and it was a true early biotechnology story. It took until the mid- or late 1980s before the PSA started creeping into routine clinical practice. It was a huge game changer in the sense that maybe 10% of my patient population was devoted to prostate cancer patients before the PSA assay, but since its introduction, I would say 80% of my patients fall into that category. I specialize in that area as a genitourinary oncologist, so my experience is a little biased, but that's the way it is today.

The PSA has been both heralded and demonized. It's been used properly and misused. But during the PSA era, the death rate from prostate cancer has gone down 40%. The PSA has also led to over diagnosis and overtreatment -- all of that is true. But at the end of the day, PSA is still the best biomarker in clinical utilization. I believe the single greatest reason for that reduction in deaths was…

Continue reading this interview:  What Andy Grove and Michael Milken Have Taught Us About Prostate Cancer

About Streetwise Reports -- The Life Sciences Report

Investors rely on The Life Sciences Report to share investment ideas for the biotech, pharmaceutical, medical device, and diagnostics industries. Our exclusive interviews with leading industry experts and analysts provide a clear picture of the causes of macro-economic shifts and the strategies that help you capitalize on developing trends.

DISCLOSURE:

Arno Therapeutics Inc. is a billboard advertiser with Streetwise Reports. Dr. Stuart Holden had final approval of the content and is wholly responsible for the validity of the statements. Opinions expressed are the opinions of Dr. Stuart Holden and not of Streetwise Reports or its officers. The interview does not constitute investment advice. Each reader is encouraged to consult with his or her individual financial professional and any action a reader takes as a result of information presented here is his or her own responsibility.

Please see Streetwise Reports' terms of use and full legal disclaimer .

Jim Patrick Email contact

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Knotch Bets Brands Need Answers, Not More Web Pages

Updated Category News Views 147

Pages are starting to look like expensive filing cabinets A website that cannot answer an agent may soon be expensive wallpaper. That is the blunt premise behind Knotch's Ace for Agents, launched Nov. 17, 2026, and frankly it lands because plenty of big companies have spent years piling pages atop pages until nobody can tell which claim is current. Knotch is pitching an...

Continue Reading
Scribd’s First Safety Report Shows Enforcement at Scale

Updated Category News Views 65

Forty-seven million enforcement actions is not a decorative statistic Scribd finally put some hard numbers on a problem most document platforms prefer to discuss in foggy corporate language. Its first transparency report, covering January through June 2026, says the company took more than 47 million moderation actions across Scribd and Slideshare. That is a hulking...

Continue Reading
Trilith Holiday Tour Blends Film Access and Giving

Updated Category News Views 39

Snow machines, trolley rides, and a mental-health subsidy are sharing the same stage in Fayetteville this holiday season. That is an unusual mix, but it fits Trilith Foundation’s stated mission better than another generic lights-and-cocoa event ever could. From Nov. 21 through Dec. 31, the Foundation is turning its guided Trilith Studios tour into a seasonal experience...

Continue Reading
Charter’s $1.5 Billion Tender Tests Debt Discipline

Updated Category News Views 152

Debt cleanup arrives with a hard ceiling Eight far-dated bond issues just got a very specific invitation from Charter Communications: hand them over for cash, but do not expect the company to write a blank check. Charter set final pricing on November 17 for tender offers covering up to $1.5 billion in aggregate consideration, excluding accrued interest and deal expenses....

Continue Reading
Voltage Energy's Microgrid Launches at RE+ 2026

Updated Category News Views 0

Voltage Energy Unveils New Power Systems In the swirling chaos of energy innovation, Voltage Energy is trying to carve its path at the heart of RE+ 2026. Out in Las Vegas, amidst the buzz of renewable energy tech, they introduced their Microgrid System (MGS) along with two new electrical balance of system (EBOS) products—the Load Break Disconnect Box (LBD) and Combiner...

Continue Reading
Azazie Tests Bridal Demand With Two East Coast Pop-Ups

Updated Category News Views 58

Wedding dresses are a miserable product to buy sight unseen, no matter how pretty the product photos look. That basic fact is why Azazie’s two East Coast pop-ups on November 21 and 22 deserve a closer look. This is not some grand retail rollout, and nobody should pretend a pair of short events rewrites the bridal market. But it is a practical test of where a...

Continue Reading
MobileX's $10 Plan Puts Holiday Pressure on Wireless

Updated Category News Views 110

A sixty-dollar commitment is a small bet, but in wireless it can become a loud little nuisance for every carrier charging far more. MobileX has rolled out a Black Friday offer giving new customers 10GB of high-speed data, unlimited talk and text, and six months of service for $60 upfront. That pencils out to $10 a month, before taxes and government surcharges, and it runs...

Continue Reading
Suntory Flowers Tests NASCAR as a Garden Retail Engine

Updated Category News Views 24

Orange sheet metal and flowering vines are an odd couple, which is precisely why this South Florida promotion has some bite. A plant marketer took a hard left turn Suntory Flowers put its Sun Parasol mandevillas alongside DGM Racing at Homestead-Miami Speedway, celebrating the millions of plants grown in South Florida. That is not a conventional horticulture play, and...

Continue Reading
Texas Community Bancshares Adds a Special Dividend

Updated Category News Views 89

Nine cents is the whole message—for the moment Texas Community Bancshares has put a little extra cash on the table, declaring a regular quarterly dividend of $0.06 per common share and a special cash dividend of $0.03 per share. Together, holders get $0.09 per share, payable on or about December 15, 2026, provided they are shareholders of record when business closes on...

Continue Reading
Bank of America AML Claims Put Controls Under Fire

Updated Category News Views 54

A $1.2 billion compliance bill has a way of making investors stop pretending controls are boring. Moore Law PLLC is urging Bank of America shareholders to contact the firm over allegations tied to the bank's anti-money-laundering and Bank Secrecy Act systems. The notice follows what it describes as landmark October 13, 2026 enforcement actions by the Treasury Department's...

Continue Reading

Top 5 Most Recently Viewed Articles

ThinkAndor® Reigns as Leading AI Platform for Virtual Care

Updated Category News Views 121

ThinkAndor® Wins Top Honors in Virtual Care Solutions Andor Health's ThinkAndor® has distinguished itself yet again as the leading **AI healthcare software infrastructure**, confirmed by recent evaluations as the best virtual care platform. This notable recognition by an acclaimed market research assessment underscores the platform's unmatched capabilities in bringing...

Continue Reading
Skanska Lands Major London Build: GBP 282M Deal

Updated Category News Views 27

A Fresh Gig in London for Skanska Skanska, the Swedish construction heavyweight is digging into London's concrete jungle with a hefty GBP 282M contract to deliver a new 23-storey commercial office building. Of course, it doesn't hurt that this project is smack-dab in the financial district, a stone's throw from the hustle and bustle of Liverpool Street Station. Looks like...

Continue Reading
Transforming Hospital Security with Innovative Visitor Management

Updated Category News Views 572

Athena Security Unveils Cutting-Edge Hospital Visitor Management System Athena Security has introduced a revolutionary Hospital Visitor Management System (VMS) designed for hospitals, providing a robust layer of security with constant operational capabilities. Controlled from a 13-inch iPad, this new system offers resilience, operating around the clock, regardless of...

Continue Reading
Clarios Partners with Scientix to Advance STEM Education

Updated Category News Views 143

Clarios Collaborates with Scientix for Sustainable STEM Education Clarios, a global leader in advanced low-voltage battery solutions and the proud home of VARTA Automotive, is excited to announce its new partnership with European Schoolnet as part of the Scientix STEM Alliance. This alliance aims to promote education in STEM (Science, Technology, Engineering, and...

Continue Reading
SCOR Maintains Timeline for 2022 Arbitration on Retrocession Treaties

Updated Category News Views 151

Overview of SCOR's Arbitration Regarding Retrocession Treaties In the evolving landscape of global reinsurance, SCOR has been actively involved in legal proceedings concerning retrocession treaties. The arbitration in question, initiated in 2022, responds to a request for enforcing treaties signed with Covéa back in June 2021. Status of the Arbitration Proceedings As...

Continue Reading